1 not yet recruiting. .
Follow Hui Peng: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Therapeutic Prospects of Faricimab Injection for Patients Affected by Neovascular Age-Related Macular Degeneration Faricimab - Neovascular Age-related Macular Degeneration(nAMD) | Not yet recruiting | Hui Peng | 35 | 2025-09-01 | 2025-07-28 |
faricimab (1)